Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population

Citation
D. Bretherton-watt et al., Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population, BR J CANC, 85(2), 2001, pp. 171-175
Citations number
34
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
85
Issue
2
Year of publication
2001
Pages
171 - 175
Database
ISI
SICI code
0007-0920(20010720)85:2<171:VDRGPA>2.0.ZU;2-6
Abstract
There is increasing evidence that vitamin D can protect against breast canc er. The actions of vitamin D are mediated via the vitamin D receptor (VDR). We have investigated whether polymorphisms in the VDR gene are associated with altered breast cancer risk in a UK Caucasian population. We recruited 241 women following a negative screening mammogram and 181 women with known breast cancer. The VDR polymorphism Bsml, an intronic 3' gene variant, was significantly associated with increased breast cancer risk: odds ratio bb vs BB genotype = 2.32 (95% Cl, 1.23-4.39). The Bsml polymorphism was in lin kage disequilibrium with a candidate translational control site, the variab le length poly (A) sequence in the 3' untranslated region. Thus, the 'L' po ly (A) variant was also associated with a similar breast cancer risk. A 5' VDR gene variant, Fokl, was not associated with breast cancer risk. Further investigations into the mechanisms of interactions of the VDR with other e nvironmental and/or genetic influences to alter breast cancer risk may lead to a new understanding of the role of vitamin D in the control of cellular and developmental pathways. (C) 2001 Cancer Research Campaign http://www.b jcancer.com.